Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
Top Story
Archived
•
November 8, 2025
•
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
Source: https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



